US Patent 8946416 Process for the synthesis of 5-(methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)-benzeneamine

Patent 8946416 was granted and assigned to Novartis on February, 2015 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Novartis

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

89464160

Patent Inventor Names

Joseph McKenna0

Wen-Chung Shieh0

Date of Patent

February 3, 2015

Patent Application Number

133534340

Date Filed

January 19, 2012

Patent Citations Received

‌

US Patent 12064430 Kinase inhibitor salts and compositions thereof

‌

US Patent 12064428 Kinase inhibitor salts and compositions thereof

Patent Primary Examiner

‌

Deepak Rao

Patent abstract

The present invention provides a new method of making compounds of formula (I):

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8946416 Process for the synthesis of 5-(methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)-benzeneamine

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API